 |
|
Focused ultrasound relieves fibroid symptoms in women
May 29, 2007OAK BROOK, Ill. -- A noninvasive ultrasound procedure effectively shrinks uterine fibroids and significantly relieves fibroid-related symptoms in women, according to the results of a multicenter clinical trial reported in the June issue of the journal Radiology. Magnetic resonance-guided, focused ultrasound surgery (MRgFUS) allows radiologists to precisely target fibroids without harming healthy surrounding tissue.
"This treatment immediately stops blood flow in the treated fibroid tissue, which results in a significant, sustained decrease in symptoms for up to 12 months," said the study's lead author, Fiona M. Fennessy, M.D., Ph.D., assistant professor of radiology at Harvard Medical School and staff radiologist at Brigham and Women's Hospital in Boston.
Uterine fibroids are benign growths of the muscle inside the uterus. According to the National Institutes of Health, at least 25 percent of women in the United States age 25 to 50 suffer from symptomatic uterine fibroids. Fibroid symptoms can include excessive menstrual bleeding, enlarged uterine size, frequent urination, pelvic pressure or pain and infertility.
According to the National Women's Health Information Center, fibroids are the primary reason for surgical removal of the uterus, accounting for approximately one-third of hysterectomies performed annually in the U.S. MRgFUS represents a noninvasive, outpatient alternative to hysterectomy.
"This treatment is ideal for older women who have completed their families and have a single or limited number of fibroids," said co-author Clare M. Tempany, M.D., professor of radiology at Harvard Medical School and director of Clinical Focused Ultrasound at Brigham and Women's Hospital.
The researchers studied 160 women with symptomatic fibroids. The women received pre-treatment MR imaging to identify and define the target fibroids. Radiologists then used MRgFUS to locate and treat the targeted fibroids while monitoring temperature changes in tissue.
Ninety-six patients were treated under the original study protocol (A), and 64 patients were treated under an optimized protocol (B). Protocol A allowed a maximum treatment time of 120 minutes and a maximum fibroid treatment volume of 100ccs (roughly six centimeters (cm) in diameter), or up to 33 percent of total fibroid volume. Protocol B allowed a maximum treatment time of 180 minutes and maximum fibroid treatment volume of 150ccs (about seven cm in diameter), or up to 33 percent of total volume in subserosal fibroids (those on the outer wall of the uterus) and 50 percent of volume in non-subserosal fibroids.
"Through this study, we've learned that MRgFUS can be optimized with newer protocols to have even better results than previously thought possible," Dr. Tempany said.
The findings showed significant symptom relief at three months and sustained relief at one year. Women treated with the optimized protocol reported greater symptom relief and quality of life improvement than those treated with the original protocol. No serious adverse effects were reported.
"We have shown that treating fibroids with an optimized, less restrictive protocol allows for treatment of a greater fibroid volume, which results in even greater symptomatic relief at clinical follow-up," Dr. Fennessy said.
Radiological Society of North America
According to the National Women's Health Information Center, fibroids are the primary reason for surgical removal of the uterus, accounting for approximately one-third of hysterectomies performed annually in the U.S. MRgFUS represents a noninvasive, outpatient alternative to hysterectomy.
"This treatment is ideal for older women who have completed their families and have a single or limited number of fibroids," said co-author Clare M. Tempany, M.D., professor of radiology at Harvard Medical School and director of Clinical Focused Ultrasound at Brigham and Women's Hospital.
The researchers studied 160 women with symptomatic fibroids. The women received pre-treatment MR imaging to identify and define the target fibroids. Radiologists then used MRgFUS to locate and treat the targeted fibroids while monitoring temperature changes in tissue.
Ninety-six patients were treated under the original study protocol (A), and 64 patients were treated under an optimized protocol (B). Protocol A allowed a maximum treatment time of 120 minutes and a maximum fibroid treatment volume of 100ccs (roughly six centimeters (cm) in diameter), or up to 33 percent of total fibroid volume. Protocol B allowed a maximum treatment time of 180 minutes and maximum fibroid treatment volume of 150ccs (about seven cm in diameter), or up to 33 percent of total volume in subserosal fibroids (those on the outer wall of the uterus) and 50 percent of volume in non-subserosal fibroids.
"Through this study, we've learned that MRgFUS can be optimized with newer protocols to have even better results than previously thought possible," Dr. Tempany said.
The findings showed significant symptom relief at three months and sustained relief at one year. Women treated with the optimized protocol reported greater symptom relief and quality of life improvement than those treated with the original protocol. No serious adverse effects were reported.
"We have shown that treating fibroids with an optimized, less restrictive protocol allows for treatment of a greater fibroid volume, which results in even greater symptomatic relief at clinical follow-up," Dr. Fennessy said.
Radiological Society of North America
Fibroids Current Events and Fibroids News RSSUC Davis researchers find decrease in hysterectomy complications
UC Davis researchers who studied hospital discharge records for nearly 650,000 California women over a 13-year period have found that complications from hysterectomies have significantly declined.
Fibroids common, but women have options
Small fibroids located just beneath the lining of the uterus (submucosal) are more likely to move to the endometrial cavity after uterine artery embolization (UAE) but usually don't cause major complications, according to a new study.
Treatment advances for fibroids, menopause
Women with fibroids and endometriosis facing the possibility of hysterectomy may now choose less invasive treatment options to preserve fertility, according to Yale professor Aydin Arici, M.D., who will direct a scientific session exploring these alternatives at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting May 3-7 in New Orleans, Louisiana.
Major surgery no longer needed for the removal of uterine fibroids
The treatment of uterine fibroids with 3T MR-guided focused ultrasound (MRgFUS) is safe, non-invasive and effective, according to a recent study conducted by researchers at Weill Cornell Medical College in New York, NY.
Minimally invasive fibroid treatment fares well in multicenter trial
A new multicenter trial found that uterine artery embolization (UAE) is a good alternative to hysterectomy in women with symptomatic fibroids. The findings of the Embolisation versus Hysterectomy (EMMY) Trial appear in the March issue of the journal Radiology.
Mayo Clinic study finds focused ultrasound treatment of uterine fibroids long term symptom relief
A noninvasive, outpatient treatment for noncancerous uterine tumors provides sustained relief from symptoms, according to a new Mayo Clinic led collaborative study.
Enhanced MR-guided focused ultrasound guidelines demonstrate improved efficacy and durability
Data released today show that MR-guided focused ultrasound (MRgFUS) is a more effective option for a broader population of uterine fibroid sufferers.
MicroRNAs Can Be Tumor Suppressors
University of Virginia researchers have discovered that microRNAs, a form of genetic material, can function as tumor suppressors in laboratory studies.
MicroRNAs as tumor suppressors
In the May 1st issue of G&D, Drs. Yong Sun Lee and Anindya Dutta (UVA) reveal that microRNAs can function as tumor suppressors in vitro.
Chance of hysterectomy predicted by multi-year study
A woman's chance of undergoing a hysterectomy can now be accurately predicted, according to new UCSF study findings.
More Fibroids Current Events and Fibroids News Articles
 | Healing Fibroids: A Doctor's Guide to a Natural Cure by Allan Warshowsky An Exciting New Approach to Regaining Health Without Surgery!Fact: By the time they reach menopause 40 percent of American women have at least one uterine fibroid; 600,000 women are diagnosed each year.Fact: Fibroids are the leading cause of hysterectomy, the second most common surgical procedure performed on women.Fact: Natural, holistic medicine can heal fibroids without invasive... |
 | What Your Doctor May Not Tell You About Fibroids: New Techniques and Therapies--Including Breakthrough Alternatives to Hysterectomy by Scott C. Goodwin, David Drum, Michael Broder Two fibroid experts reveal the little-known facts about preventing and treating fibroid tumors--without surgery. Fibroid tumors are the leading reason why more than 500,000 American women have hysterectomies each year. Fibroids are benign tumors that arise from the smooth muscle layer of the uterus. As they grow larger, they can put pressure on neighboring organs and tissues, causing pain,... |
 | Fibroid Tumor and Endometriosis Self Help Book by Susan M. Lark |
 | Fibroids: The Complete Guide to Taking Charge of Your Physical, Emotional and Sexual Well-Being by Johanna Skilling One out of every four women in the United States has uterine fibroids. Yet all too often they're left with more questions than answers. In this fully revised and updated edition of Fibroids, Johanna Skilling, who suffers from fibroids herself, offers a total resource for women with the condition. Skilling covers the full range of issues related to fibroids, including testing and treatment... |
 | Uterine Fibroids: The Complete Guide (A Johns Hopkins Press Health Book) by Elizabeth A. Stewart You've called in sick today. Your back and legs hurt. Your abdomen is bloated and more than a little uncomfortable. You are having your period, and the bleeding is so heavy you can't even think about leaving the house. You have uterine fibroids.One in every four women see their lives affected by uterine fibroids, which can cause heavy bleeding, abdominal bloating, pain, and infertility. The... |
 | The First Year--Fibroids: An Essential Guide for the Newly Diagnosed by Johanna Skilling Though an estimated eight in ten women in America will be diagnosed with fibroids during their lifetime, it remains one of the most ambiguous conditions a woman can have. In the tradition of the other titles in the First Year series, The First Year—Fibroids uses a unique approach, guiding readers through practical and straightforward steps for the first seven days following diagnosis, then the... |
 | Natural Treatment of Fibroid Tumors and Endometriosis by Susan M. Lark Effective solutions for problems that affect... |
 | Sex, Lies, and the Truth about Uterine Fibroids by Carla Dionne The most authoritative book available on uterine fibroids. Approximately one in four women in the United States will be diagnosed with uterine fibroids in her lifetime. And for many women, the only course of treatment they may be offered is hysterectomy. As a result, hysterectomy is the number-one surgical procedure undergone by women in the United States, with some forty-five percent of these... |
 | It's a Sistah Thing: A Guide to Understanding and Dealing with Fibroids for Black Women by Monique Brown |
 | Fibroid Tumors Healed Naturally: A Personal Journey Shared With Specific How-To's by Faye Hardaway This book was written by a woman who was actually healed naturally of fibroid tumors and is supported by a foreword written by a board certified doctor, obstetrician /... |
| © 2008 BrightSurf.com |